Effects of valsartan on the progression of renal and cardiovascular disease - Kanagawa Valsartan Trial (KVT)

Trial Profile

Effects of valsartan on the progression of renal and cardiovascular disease - Kanagawa Valsartan Trial (KVT)

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Apr 2015

At a glance

  • Drugs Valsartan (Primary) ; ACE inhibitors; Beta-adrenergic receptor antagonists; Calcium channel antagonists; Diuretics
  • Indications Cardiovascular disorders; Hypertension; Kidney disorders
  • Focus Therapeutic Use
  • Acronyms KVT
  • Most Recent Events

    • 24 Mar 2009 Actual patient number (312) added, actual end date (Apr 2008) added, additional lead trial centre/investigator identified as reported by ClinicalTrials.gov.
    • 24 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top